BioSpace News Archive

Business

Capricor and USAISR Announce Collaboration to Investigate Exosome Platform to Treat Injured Troops

Capricor Therapeutics announced it has entered into an agreement with the U.S. Army Institute of Surgical Research (USAISR) to study the potential for the company’s next-generation investigational therapeutic platform, designated CAP-2003

July 17, 2018
·
6 min read
Policy

Envolve Earns NCQA Utilization Management Accreditation

Centene Corporation announced that its wholly-owned subsidiary, Envolve Pharmacy Solutions, was accredited by the National Committee for Quality Assurance (NCQA) in Utilization Management (UM).

July 17, 2018
·
10 min read
Deals

China YCT International Group Files Registration Statement on Form S-1 and Application for NASDAQ Capital Market Listing

China YCT International Group, Inc. announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission relating to a proposed public offering of shares of its common stock

July 17, 2018
·
3 min read
BioCapital

Ascentage Pharma Raises $150 Million in Series C Financing

Funding to support broad and innovative product pipeline of apoptosis-targeted candidates and build-out of state-of-the-art R&D centers and manufacturing facilities

July 17, 2018
·
3 min read
Biotech Bay

AlacrityCare and Myia Join VivaLNK Developer Program to Innovate Remote Patient Monitoring for Cancer Treatment and Cardiovascular Events

VivaLNK Developer Program gives healthcare application solutions access to wearable devices that are both consumer-friendly and medical-grade quality

July 17, 2018
·
3 min read
Pharm Country

Qfix Releases New Product to Improve Brachytherapy Workflows and Patient Transport

Qfix today announces the launch of the New Symphony™ Patient Transport System which offers enhanced and simplified patient transport and transfer between various imaging and treatment modalities.

July 17, 2018
·
1 min read
Genetown

HotSpot Therapeutics Completes $45 Million Series A Financing to Advance New Approach to Allosteric Drug Discovery

First and only technology platform to systematically identify and target “hotspots” - a unique family of allosteric sites used by nature to regulate protein function

July 17, 2018
·
6 min read
Drug Development

Viking Therapeutics Announces VK5211 Phase 2 Study Results Selected for Plenary Oral Presentation at ASBMR 2018 Annual Meeting

Presentation to Highlight Data for Novel, Orally Available SARM in Patients Recovering from Hip Fracture Surgery

July 17, 2018
·
5 min read
FDA

Gamida Cell Receives Orphan Drug Designation from the FDA for NiCord® as a Treatment for Hematopoietic Stem Cell Transplantation

Gamida Cell announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for NiCord as a treatment for hematopoietic stem cell transplantation (HSCT).

July 17, 2018
·
2 min read
Policy

Can-Fite Granted Australian and Chinese Patents for Erectile Dysfunction Drug

Erectile dysfunction market is estimated to reach $3.2 billion by 2022

July 17, 2018
·
5 min read